Update on aromatase inhibitors in breast cancer-Reference-Cited by-同舟云学术

Update on aromatase inhibitors in breast cancer

Published:2006-02 Issue:1 Volume:18 Page:41-46
ISSN:1040-872X
Container-title:Current Opinion in Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Gould Richard E.,Garcia Agustin A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference36 articles.

1. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases;Beatson;Lancet,1896

2. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies;J. Natl. Cancer Inst.,2002

3. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values;Cancer Epidemiol. Biomarkers Prev.,2003

4. Tamoxifen in the treatment of breast cancer;Osborne;N. Engl. J. Med.,1998

5. Sources of estrogen and their importance;Simpson;J. Steroid Biochem. Mol. Biol.,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoresistance and targeted therapies in ovarian and endometrial cancers;Oncotarget;2016-12-19

2. Uterine Sarcoma and Aromatase Inhibitors: Tom Baker Cancer Centre Experience and Review of the Literature;International Journal of Gynecologic Cancer;2012-07

3. Use of Aromatase Inhibitors as First-and Second-Line Medical Therapy in Patients With Endometrial Adenocarcinoma: A Retrospective Study;Journal of Obstetrics and Gynaecology Canada;2012-07

4. Exemestane;Drugs;2009-05

5. Hormonal therapies and gynaecological cancers;Best Practice & Research Clinical Obstetrics & Gynaecology;2008-04